Medications

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had oxycodone dispensed to them by a community pharmacy, by year (2019 to 2023), ethnic group, age group, and gender. 

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had morphine dispensed to them by a community pharmacy for six weeks or more, between 2019 and 2023.  

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had morphine dispensed to them by a community pharmacy, by year (2019 to 2023), ethnic group, age group, and gender. 

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had received a strong opioid and had a public hospital event in the eight days prior to dispensing of a strong opioid during the calendar year. Data is presented by year (2019 to 2023), ethnic group, age, gender and health district.  

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had fentanyl dispensed to them by a community pharmacy for six or more weeks in a year (2019 to 2023). 

This indicator shows the number and rate per 1,000 of the PHO-enrolled population who had fentanyl dispensed to them by a community pharmacy, by year (2019 to 2023). 

This indicator shows the number and percent of people with diabetes receiving metformin regularly. Regular use was defined as metformin dispensed in three or more quarters in a year. 

This indicator shows the number and percent of people with diabetes dispensed insulin regularly. Regular use was defined as insulin dispensed in three or more quarters in a year.

This measure shows the percentage of people with diabetes admitted to hospital with diabetic ketoacidosis as the primary diagnosis.

This indicator shows the number and percent of people with diabetes receiving angiotensin converting enzyme inhibitor (ACEI) or an angiotensin receptor blocker (ARB) in three or four quarters in the relevant year